Longevity of modified standard short treatment regimens for rifampicin-resistant tuberculosis

T Decroo; A Mesic; I Decuyper

Longevity of modified standard short treatment regimens for rifampicin-resistant tuberculosis

HIV and Tuberculosis

Research output: Contribution to journal › Editorial

Original language	English
Journal	Lancet Infectious Diseases
Volume	24
Issue number	10
Pages (from-to)	1069-1071
Number of pages	3
ISSN	1473-3099
Publication status	Published - 2024

Cite this

@article{3275601ea1e145eaa3cb778d97942de8,

title = "Longevity of modified standard short treatment regimens for rifampicin-resistant tuberculosis",

author = "T Decroo and A Mesic and I Decuyper",

note = "FTX",

year = "2024",

language = "English",

volume = "24",

pages = "1069--1071",

journal = "Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier",

number = "10",

}

TY - JOUR

T1 - Longevity of modified standard short treatment regimens for rifampicin-resistant tuberculosis

AU - Decroo, T

AU - Mesic, A

AU - Decuyper, I

N1 - FTX

PY - 2024

Y1 - 2024

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=itm_wosliteitg&SrcAuth=WosAPI&KeyUT=WOS:001327472600001&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Editorial

C2 - 38880113

SN - 1473-3099

VL - 24

SP - 1069

EP - 1071

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

IS - 10

ER -

Longevity of modified standard short treatment regimens for rifampicin-resistant tuberculosis

Other files and links

Cite this